NO20091735L - Radiofluorering - Google Patents

Radiofluorering

Info

Publication number
NO20091735L
NO20091735L NO20091735A NO20091735A NO20091735L NO 20091735 L NO20091735 L NO 20091735L NO 20091735 A NO20091735 A NO 20091735A NO 20091735 A NO20091735 A NO 20091735A NO 20091735 L NO20091735 L NO 20091735L
Authority
NO
Norway
Prior art keywords
compounds
radio fluorination
labeled
fluorination
radio
Prior art date
Application number
NO20091735A
Other languages
English (en)
Inventor
Ulrich Klar
Ananth Srinivasan
Timo Stellfeld
Simon Ametamey
Lutz Lehmann
Ulrike Rohn
Aileen Hohne
Linjing Mu
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06076823A external-priority patent/EP1908472A1/en
Priority claimed from EP06076869A external-priority patent/EP1911452A1/en
Priority claimed from EP07090043A external-priority patent/EP1970064A1/en
Priority claimed from EP07090079A external-priority patent/EP1985624A3/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20091735L publication Critical patent/NO20091735L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0896—Compounds with a Si-H linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/12—Organo silicon halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nuclear Medicine (AREA)

Abstract

Den foreliggende oppfinnelse vedrører nye forbindelser egnet for radioaktiv merking, eller allerede radioaktivt merket, med 18F, fremgangsmåter for fremstilling av slike forbindelser og anvendelse av slike forbindelser til diagnostisk avbilding. Slike merkede forbindelser er kjennetegnet ved formel II. Hvor restene F, R1,R2, B1,2,Y1,2, Z1,2 og E har betydningen som definert i beskrivelsen og kravene.
NO20091735A 2006-10-02 2009-04-30 Radiofluorering NO20091735L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06076823A EP1908472A1 (en) 2006-10-02 2006-10-02 Silicon derivatives for PET imaging
EP06076869A EP1911452A1 (en) 2006-10-11 2006-10-11 Silicon-derivates for PET-Imaging
EP07090043A EP1970064A1 (en) 2007-03-12 2007-03-12 Silicon-derivatives for pet-imaging
EP07090079A EP1985624A3 (en) 2007-04-23 2007-04-23 Single step method of radiofluorination of biologically active compounds or biomolecules
PCT/EP2007/008044 WO2008040441A2 (en) 2006-10-02 2007-09-07 Silicon derivatives for pet imaging

Publications (1)

Publication Number Publication Date
NO20091735L true NO20091735L (no) 2009-06-30

Family

ID=39030886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091735A NO20091735L (no) 2006-10-02 2009-04-30 Radiofluorering

Country Status (21)

Country Link
US (1) US20090035215A1 (no)
EP (1) EP2074135A2 (no)
JP (1) JP2010505776A (no)
KR (1) KR20090085599A (no)
AR (1) AR062795A1 (no)
AU (1) AU2007304508A1 (no)
BR (1) BRPI0719956A2 (no)
CA (1) CA2664700A1 (no)
CO (1) CO6180444A2 (no)
CR (1) CR10703A (no)
IL (1) IL197817A0 (no)
MA (1) MA30824B1 (no)
MX (1) MX2009003617A (no)
NO (1) NO20091735L (no)
PA (1) PA8747601A1 (no)
PE (1) PE20081173A1 (no)
SV (1) SV2009003205A (no)
TN (1) TN2009000100A1 (no)
TW (1) TW200820988A (no)
UY (1) UY30596A1 (no)
WO (1) WO2008040441A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9285360B2 (en) 2010-01-25 2016-03-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Silylated biomolecules
JP5717138B2 (ja) * 2011-05-23 2015-05-13 独立行政法人産業技術総合研究所 タンパク質固定化表面修飾材料
JP6398973B2 (ja) * 2013-06-06 2018-10-03 日産化学株式会社 液晶配向剤、液晶配向膜及び液晶表示素子
CN107667109B (zh) * 2015-05-26 2021-08-03 加利福尼亚大学董事会 可用于分子和生物分子的18f标记的新的杂芳族硅-氟化物-受体及其制备方法
US11464784B2 (en) 2017-09-15 2022-10-11 The Regents Of The University Of California Inhibition of aminocylase 3 (AA3) in the treatment of cancer
US20230226228A1 (en) * 2020-05-04 2023-07-20 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for detection of bacterial infection
EP4218831B1 (en) * 2020-09-28 2025-03-05 National Institutes for Quantum Science and Technology Method for producing radioactive labeled substance, device for producing radioactive labeled substance, and method for evaporating and concentrating radioactive metal nuclide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
US5732578A (en) * 1995-02-24 1998-03-31 Hyundai Metal Co., Ltd. Device for maintaining the horizontality of a door lock lever
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6639076B1 (en) * 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
DE60022508T2 (de) * 1999-06-14 2006-06-08 Eli Lilly And Co., Indianapolis Inhibitoren von serin proteasen
AU2002228725A1 (en) * 2000-11-30 2002-06-11 Advanced Research And Technology Institute, Inc. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
US7342095B2 (en) * 2003-02-20 2008-03-11 University Of South Florida Peptidomimetic inhibitors of STAT activity and uses thereof
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
CA2555597C (en) * 2004-02-13 2016-06-14 The University Of British Columbia Radiolabeled compounds and compositions, their precursors and methods for their production
US20080029548A1 (en) * 2006-05-05 2008-02-07 Ann De Wree Fabric treatment dispensing package

Also Published As

Publication number Publication date
PE20081173A1 (es) 2008-11-06
US20090035215A1 (en) 2009-02-05
IL197817A0 (en) 2009-12-24
MX2009003617A (es) 2009-04-22
CO6180444A2 (es) 2010-07-19
CR10703A (es) 2009-06-25
TN2009000100A1 (en) 2010-08-19
MA30824B1 (fr) 2009-10-01
WO2008040441A3 (en) 2009-01-08
WO2008040441A2 (en) 2008-04-10
BRPI0719956A2 (pt) 2014-04-29
PA8747601A1 (es) 2009-08-26
UY30596A1 (es) 2008-05-02
TW200820988A (en) 2008-05-16
EP2074135A2 (en) 2009-07-01
SV2009003205A (es) 2009-10-19
AR062795A1 (es) 2008-12-03
JP2010505776A (ja) 2010-02-25
AU2007304508A8 (en) 2009-05-14
AU2007304508A1 (en) 2008-04-10
CA2664700A1 (en) 2008-04-10
KR20090085599A (ko) 2009-08-07

Similar Documents

Publication Publication Date Title
NO20091428L (no) Forbindelser og metoder for 18F-merkede midler
NO20091735L (no) Radiofluorering
NO20083598L (no) Karbosykliske og heterosykliske arylsulfoner som inhibitorer av gamma-sekretase
EP2248869A3 (de) Verbindungen für organische elektronische Vorrichtungen
MX388479B (es) Metodos y aparatos para sintetizar agentes formadores de imagen e intermedios de estos.
EA201100301A1 (ru) Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения
CR10694A (es) Compuestos antagonistas del receptor de glucagon, composiciones que contienen dichos compuestos y procedimientos de uso
ATE555105T1 (de) Heterocyclische fxr-bindende verbindungen
WO2010063700A3 (en) Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides
NO20083153L (no) Kjemiske forbindelser
MX2010009854A (es) Agente para liberacion de sustancia funcional.
NO20055688L (no) Organiske forbindelser
WO2009052970A3 (en) Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
FR2940266B1 (fr) Solide cristallise im-20 et son procede de preparation
WO2009127718A3 (en) Novel microbiocides
ATE536864T1 (de) Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung
BRPI1008191A8 (pt) Composto, processo para preparação de monoidrato de l-glicose, composição, método para limpeza de cólon, kit de limpeza de cólon
EP1917542A4 (en) Method for tomographic inversion by matrix transformation
AU2010332841A8 (en) Prostate specific membrane antigen inhibitors
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
EP2447269A4 (en) GADOLINIUM COMPLEX, METHOD FOR THE PRODUCTION THEREOF AND MRI-CONTRASTING AGENT THEREWITH
DE602006008639D1 (de) Automatisches radioaktives markierungsverafhren
EP2116542A4 (en) SOLID OF A MAKROLIDE COMPOUND, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
WO2009013358A3 (en) Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions
FR2923476B1 (fr) Solide cristalise im-17 et son procede de preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application